Search


 
Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.001 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
27-Apr-2010SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis.Luthi-Carter, R; Taylor, DM; Pallos, J; Lambert, E; Amore, A; Parker, A; Moffitt, H; Smith, DL; Runne, H; Gokce, O; Kuhn, A; Xiang, Z; Maxwell, MM; Reeves, SA; Bates, GP; Neri, C; Thompson, LM; Marsh, JL; Kazantsev, AGJournal Article
Aug-2010Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease.Benn, CL; Luthi-Carter, R; Kuhn, A; Sadri-Vakili, G; Blankson, KL; Dalai, SC; Goldstein, DR; Spires, TL; Pritchard, J; Olson, JM; van Dellen A; Hannan, AJ; Cha, JHJournal Article
Jan-2012Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.Jiang, M; Wang, J; Fu, J; Du, L; Jeong, H; West, T; Xiang, L; Peng, Q; Hou, Z; Cai, H; Seredenina, T; Arbez, N; Zhu, S; Sommers, K; Qian, J; Zhang, J; Mori, S; Yang, XW; Tamashiro, KL; Aja, S; Moran, TH; Luthi-Carter, R; Martin, B; Maudsley, S; Mattson, MP; Cichewicz, RH; Ross, CA; Holtzman, DM; Krainc, D; Duan, WJournal Article
15-Mar-2011In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.Thomas, EA; Coppola, G; Tang, B; Kuhn, A; Kim, S; Geschwind, DH; Brown, TB; Luthi-Carter, R; Ehrlich, MEJournal Article
Apr-2009A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease.Zabel, C; Mao, L; Woodman, B; Rohe, M; Wacker, MA; Kläre, Y; Koppelstätter, A; Nebrich, G; Klein, O; Grams, S; Strand, A; Luthi-Carter, R; Hartl, D; Klose, J; Bates, GPJournal Article
Jan-2009Implication of the JNK pathway in a rat model of Huntington's disease.Perrin, V; Dufour, N; Raoul, C; Hassig, R; Brouillet, E; Aebischer, P; Luthi-Carter, R; Déglon, NJournal Article
Mar-2009Sustained effects of nonallele-specific Huntingtin silencing.Drouet, V; Perrin, V; Hassig, R; Dufour, N; Auregan, G; Alves, S; Bonvento, G; Brouillet, E; Luthi-Carter, R; Hantraye, P; Déglon, NJournal Article
24-Sep-2008Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry.Runne, H; Régulier, E; Kuhn, A; Zala, D; Gokce, O; Perrin, V; Sick, B; Aebischer, P; Déglon, N; Luthi-Carter, RJournal Article
Jan-2008Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo.Charvin, D; Roze, E; Perrin, V; Deyts, C; Betuing, S; Pagès, C; Régulier, E; Luthi-Carter, R; Brouillet, E; Déglon, N; Caboche, JJournal Article
May-2007Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease.Perrin, V.; Régulier, E.; Abbas-Terki, T.; Hassig, R.; Brouillet, E.; Aebischer, P.; Luthi-Carter, R.; Déglon, N.Journal Article